中船漢光(300847.SZ)選舉張海君為董事長 蘇電禮為總經理
格隆匯3月22日丨中船漢光(300847.SZ)宣佈,公司董事會於近日收到董事長張民忠、總經理汪學文的辭職報吿。因工作原因,張民忠申請辭去董事長職務,汪學文申請辭去總經理職務。張民忠、汪學文辭去前述職務後仍擔任公司第四屆董事會董事職務。
公司於2021年3月22日召開了第四屆董事會第九次會議,審議通過了《關於變更公司董事長的議案》、《關於變更公司總經理的議案》。董事會同意選舉張海君為公司第四屆董事會董事長,任期自該次董事會審議通過之日起至第四屆董事會屆滿止;董事會同意聘任蘇電禮為公司總經理,任期自該次董事會審議通過之日起至第四屆董事會屆滿止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.